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SOD1A4V aggregation alters ubiquitin homeostasis in a cell model of
ALS
Abstract

A hallmark of amyotrophic lateral sclerosis (ALS) pathology is the accumulation of ubiquitylated protein
inclusions within motor neurons. Recent studies suggest the sequestration of ubiquitin (Ub) into inclusions
reduces the availability of free Ub, which is essential for cellular function and survival. However, the dynamics
of the Ub landscape in ALS have not yet been described. Here, we show that Ub homeostasis is altered in a
cell model of ALS induced by expressing mutant SOD1 (SOD1A4V). By monitoring the distribution of Ub in
cells expressing SOD1A4V, we show that Ub is present at the earliest stages of SOD1A4V aggregation, and that
cells containing SOD1A4V aggregates have greater ubiquitin-proteasome system (UPS) dysfunction.
Furthermore, SOD1A4V aggregation is associated with the redistribution of Ub and depletion of the free Ub
pool. Ubiquitomics analysis indicates that expression of SOD1A4V is associated with a shift of Ub to a pool of
supersaturated proteins, including those associated with oxidative phosphorylation and metabolism,
corresponding with altered mitochondrial morphology and function. Taken together, these results suggest
that misfolded SOD1 contributes to UPS dysfunction and that Ub homeostasis is an important target for
monitoring pathological changes in ALS.
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RESEARCH ARTICLE

SOD1A4V aggregation alters ubiquitin homeostasis in a cell
model of ALS

ABSTRACT
A hallmark of amyotrophic lateral sclerosis (ALS) pathology is the
accumulation of ubiquitylated protein inclusions within motor
neurons. Recent studies suggest the sequestration of ubiquitin (Ub)
into inclusions reduces the availability of free Ub, which is essential
for cellular function and survival. However, the dynamics of the Ub
landscape in ALS have not yet been described. Here, we show that
Ub homeostasis is altered in a cell model of ALS induced by
expressing mutant SOD1 (SOD1A4V). By monitoring the distribution
of Ub in cells expressing SOD1A4V, we show that Ub is present at the
earliest stages of SOD1A4V aggregation, and that cells containing
SOD1A4V aggregates have greater ubiquitin-proteasome system
(UPS) dysfunction. Furthermore, SOD1A4V aggregation is associated
with the redistribution of Ub and depletion of the free Ub pool.
Ubiquitomics analysis indicates that expression of SOD1A4V is
associated with a shift of Ub to a pool of supersaturated proteins,
including those associated with oxidative phosphorylation and
metabolism, corresponding with altered mitochondrial morphology
and function. Taken together, these results suggest that misfolded
SOD1 contributes to UPS dysfunction and that Ub homeostasis is an
important target for monitoring pathological changes in ALS.
This article has an associated First Person interview with the first
author of the paper.
KEY WORDS: Protein aggregation, Ubiquitin, SOD1, ALS,
Supersaturation, Proteostasis, Neurodegeneration, Ubiquitomics,
Degron, Proteasome

INTRODUCTION

Amyotrophic lateral sclerosis (ALS, also known as motor neuron
disease, MND) is a progressive neurodegenerative disease leading to
paralysis of voluntary muscles due to the death of motor neurons in the
brain and spinal cord. The prognosis of ALS is poor, usually leading to
death within 2 to 5 years of first symptoms. A fraction of patients
also develop clinical or subclinical frontotemporal dementia (FTD)
(Turner et al., 2013). In most cases of ALS, the cause remains
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unknown (sporadic ALS; sALS). However, ∼10% of cases are
inherited (familial ALS; fALS). A large proportion (20%) of fALS
cases can be attributed to mutations in the gene encoding superoxide
dismutase 1 (SOD1) (Chen et al., 2013). SOD1 was the first gene
discovered to cause fALS and is also the most widely studied. There are
now over 20 genes known to cause ALS (Chen et al., 2013), including
a growing list of genes associated with dysregulation of ubiquitin
(Ub) signalling. Genetic mutations in VCP, SQSTM1, UBQLN2 and
OPTN have all been associated with ALS, and are all part of the protein
degradation machinery of the cell. In addition, recently discovered
mutations in TBK1 (Cirulli et al., 2015) and CCNF (Williams et al.,
2016) add to this growing list of degradation machinery associated
with ALS. The precise role of each of these genes in the homeostasis
of Ub is unknown, but Ub sequestration into insoluble inclusions is
common to all forms of ALS (Ciryam et al., 2017).
Abnormal accumulation of proteins into insoluble aggregates
is a hallmark of many neurodegenerative diseases, including
Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and
ALS (Yerbury et al., 2016). In the context of ALS, there is growing
evidence that a correlation exists between protein aggregate load and
neuronal loss in the ALS spinal cord (Giordana et al., 2010;
Brettschneider et al., 2014; Ticozzi et al., 2010; Leigh et al., 1991;
Strong et al., 2005). Our previous work showed a correlation between
in vitro aggregation propensity and rate of disease progression
(McAlary et al., 2016), suggesting that protein aggregates are
intimately linked with motor neuron cell death. Recent work also
indicates that protein misfolding and aggregation may be responsible
for disease progression through a prion-like propagation throughout
the nervous system (Strong et al., 2005; Zeineddine et al., 2015;
Münch et al., 2011; Sundaramoorthy et al., 2013; Grad et al., 2014).
It is unlikely that misfolding alone is responsible for the disease,
and post-translational modifications also seem to play an important
role (McAlary et al., 2013). One crucial post-translational modification
is ubiquitylation, which is necessary for protein degradation.
Degradation defects that lead to inclusion formation are associated
with a tendency for cells to be dysfunctional and undergo apoptosis
(Atkin et al., 2014; Tsvetkov et al., 2013; Weisberg et al., 2012).
Inclusions associated with neurodegeneration consist of a variety
of proteins including proteins specific to the disease [e.g. Aβ and
tau in Alzheimer’s disease (Chiti and Dobson, 2006)], proteins
associated with cellular quality control machinery [e.g. molecular
chaperones (Sherman and Goldberg, 2001; Yerbury and Kumita,
2010) and the proteasome (Huang and Figueiredo-Pereira, 2010)]
and other unrelated aggregation-prone proteins (Ciryam et al.,
2013, 2015). Based on analysis of human tissue, it has been shown
that a large number of proteins are supersaturated in wild-type and
ALS-associated mutant cells, with cellular concentrations under
wild-type conditions that exceed their predicted solubility (Ciryam
et al., 2013, 2015). These supersaturated proteins are associated
with the biochemical pathways underpinning a variety of
1
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neurodegenerative diseases. Most recently, we have shown that
proteins co-aggregating with SOD1, TDP-43 (also known as
TARDBP) and FUS inclusions are supersaturated (Ciryam et al.,
2017), consistent with a collapse of motor neuron protein homeostasis
in ALS. Others have found that the proteins that co-aggregate with
c9orf72 dipeptide repeats in cell models are also supersaturated
(Boeynaems et al., 2017). The composition of inclusions found in
ALS varies considerably depending on whether the disease is sporadic
or familial, and the genetics of the familial forms.
Ub is a pervasive feature of inclusions in ALS, regardless of
underlying genetic aetiology. Ub is a versatile signalling molecule
responsible for controlling an array of cellular pathways including
transcription, translation, vehicle transport and apoptosis (Hershko
and Ciechanover, 1998). Ub labels substrate proteins via a highly
ordered multi-step enzymatic cascade with specific differences in
the length and topology of poly-ubiquitin chains determining a
range of signalling outcomes, including proteolytic degradation via
the proteasome (Ciechanover and Brundin, 2003; Pickart, 2001).
Inside cells, Ub exists in a dynamic equilibrium between free Ub
and Ub conjugates, and its conjugation to proteins is controlled by
the opposing actions of Ub ligases and deubiquitylating enzymes
(DUBs) (Dantuma et al., 2006; Groothuis et al., 2006). Recently, it
has been proposed that the sequestration of Ub into insoluble
aggregates may deplete the free Ub pool required by many essential
cellular processes (Groothuis et al., 2006).
Although mounting genetic and functional evidence suggests an
important role for the UPS in the development of ALS pathology, the
distribution and availability of Ub in ALS models has not yet been
described. In the work reported here, we sought to characterise the Ub
landscape in a cell-based SOD1 model of ALS (Fig. S1). By following
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the distribution of fluorescently labelled Ub in live cells expressing
mutant SOD1 (SOD1A4V), we show that Ub homeostasis is disrupted
in cells containing aggregates of SOD1A4V. The aggregation of
SOD1A4V leads to an accumulation of the proteasome reporter
tdTomatoCL1, indicative of UPS dysfunction. This dysfunction was
further supported by the redistribution of the Ub pool and decrease
in free Ub levels observed in cells with SOD1A4V aggregates.
Moreover, ubiquitome analysis confirmed that misfolded SOD1 was
associated with Ub redistribution and subsequent alterations to
mitochondrial morphology. This report highlights that disruption to
Ub homeostasis is associated with aggregation of misfolded proteins
and may play an important role in the pathogenesis of ALS.
RESULTS
SOD1A4V aggregates contain Ub at the earliest detectable
stages of aggregation

We previously showed that all cellular SOD1 aggregates contained
Ub at the time points tested (Farrawell et al., 2015). Here, we used
real-time imaging using a Ub fusion protein to follow inclusion
formation in a single cell from its genesis until it had taken up a large
proportion of the cytoplasm. Previous work has demonstrated that
GFP–Ub fusions behave identically to endogenous Ub and provide
a robust fluorescent indicator of Ub distribution (Dantuma et al.,
2006). We created a mCherry–Ub fusion protein that behaved in a
similar manner to the GFP fusion protein (Fig. S2). Ub was
observed in foci at the earliest detectable stages of SOD1A4V
aggregation (Fig. 1A, see insert). Ub was continuously added to
inclusions throughout their formation, as was SOD1A4V (Fig. 1A;
Fig. S3). Approximately 51% of cellular ubiquitin was detected in
SOD1A4V aggregates (Fig. 1B).
Fig. 1. SOD1A4V co-aggregates with Ub.
(A) NSC-34 cells co-transfected with SOD1A4V–GFP
and mRFP–Ub were imaged every 15 min for 17 h.
(B) Ub incorporation into SOD1A4V inclusions
was quantified using ImageJ. (C) NSC-34 cells
overexpressing SOD1A4V–GFP were fixed,
permeabilised and stained for K48-linked and
K63-linked polyubiquitin chains at 48 h post
transfection. (D) The spinal cord from the SOD1G93A
mouse was fixed, permeabilised and stained for
neuron-specific βIII tubulin, SOD1 and K48-linked Ub.
Colocalization of SOD1 and Ub is indicated with
arrows. Scale bars: 10 µm.
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To ensure that the Ub accumulation in SOD1A4V inclusions
was not an artefact of Ub overexpression, we next probed for
endogenous Ub using antibodies. SOD1A4V expression causes
inclusions in ∼15% of NSC-34 cells (Fig. S4), and in those cells that
contain inclusions we observed a high degree of overlap between
SOD1A4V aggregates and Ub when using both antibodies specific to
K48 and K63 chains (Fig. 1C). We also found that SOD1G93A
aggregates contained Ub K48-linked chains in SOD1G93A mouse
spinal motor neurons (Fig. 1D).
Cells with SOD1A4V aggregates have increased UPS
dysfunction

We previously showed that a UPS reporter containing a CL1 degron
peptide that is subject to rapid degradation accumulates to
significantly higher amounts in ALS patient fibroblasts compared
to controls, suggesting an overwhelmed UPS (Yang et al., 2015).
Work from others suggests that SOD1 aggregates are toxic because
they interfere with the quality control function of the juxtanuclear
quality control compartment (JUNQ) (Weisberg et al., 2012). To
examine the relationship between SOD1 aggregation and UPS
dysfunction, we used transiently transfected NSC-34 cells that
contained SOD1A4V–GFP and tdTomatoCL1. We initially used flow
cytometry to examine the effect of proteasome inhibition on reporter
accumulation. While there was a significant difference in reporter
signal between cells expressing wild-type SOD1 (SOD1WT) and
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those expressing SOD1A4V, both cell lines showed a similar dosedependent increase in reporter signal with MG132 treatment
(Fig. 2A). This suggests that, while SOD1A4V expression causes
significant UPS disruption, there is no specific vulnerability to
proteasome inhibition of cells expressing mutant SOD1A4V
compared to SOD1WT-expressing cells.
However, this analysis examined the entire population of SOD1WTor SOD1A4V-expressing cells and previous work using a similar
CL1-containing fluorescent reporter suggests that the aggregation of
Huntingtin and CFTR cause UPS dysfunction (Bence et al., 2001).
We hypothesised that inclusions formed by mutant SOD1 might
influence UPS activity in a similar fashion, a phenomenon that may
not be observed when analysing the entire population of cells, given
that only 15% of NSC-34 cells expressing SOD1A4V produce
inclusions (Fig. S4). In order to identify cells with SOD1A4V
inclusions in our flow cytometry data, we tested the relationship
between aggregation and total cellular fluorescence (Fig. 2B). Cells
were transiently transfected with SOD1A4V–GFP and imaged 48 h
post transfection using confocal microscopy. The total cellular
fluorescence for individual cells was plotted for both cells with and
without inclusions. The fluorescence of both populations was
normally distributed (Fig. 2B). The mean fluorescence of cells
containing aggregates was significantly greater than that of cells
without aggregates (Fig. 3C), presumably due to continued
accumulation of SOD1 into inclusions. However, there was
Fig. 2. Mutant SOD1A4V alters UPS
activity. (A) Dose-dependent response of
UPS activity (tdTomatoCL1 fluorescence) in
NSC-34 cells co-transfected with SOD1WT–
GFP or SODA4V–GFP after overnight
treatment with the indicated concentration
of the proteasome inhibitor MG132. Data
represent mean±s.e.m. tdTomatoCL1
fluorescence (n=3). (B) Frequency
distribution analysis of SOD1A4V–GFP
fluorescence was performed on cells
expressing soluble (diffuse) SOD1A4V and
aggregated SOD1A4V. (C) Cells containing
SOD1A4V aggregates (Agg) exhibited
significantly higher fluorescence than cells
that did not contain aggregates. Data shown
are mean±s.e.m. (n≥100, combined from
four independent experiments). (D) 80% of
cells expressing the highest SOD1A4V–GFP
signal (top 10% of GFP-expressing cells)
contained aggregates. Data shown are mean
±s.e.m. from four independent experiments
where a minimum of 100 cells were counted.
(E) Cells expressing the highest GFP signal
(top 10% of GFP-expressing cells) typically
contained aggregates and revealed greater
significant differences in tdTomatoCL1
fluorescence between cells expressing
SOD1WT and SOD1A4V. **P<0.01;
***P<0.001; ****P<0.0001 (one-way ANOVA
with a Tukey’s multiple comparison post
test). Scale bars: 10 µm.
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Fig. 3. Ub distribution is not significantly altered in cells containing SOD1A4V aggregates. (A) NSC-34 cells co-transfected with SOD1WT–GFP or SOD1A4V–
GFP (cells classified according to whether SOD1A4V was either soluble or insoluble) and mCherry–Ub were photobleached in either the nucleus or cytoplasm,
and recovery of Ub fluorescence was monitored for 120 s. Data shown are means±s.e.m. (n=3) and are representative of three independent experiments.
(B) Representative confocal images of pre-bleach, post-bleach and the recovery endpoint (final read) are shown, with the ROI marked in yellow. Scale bars:
10 µm. (C) Diffusion rates (T1/2) of mCherry–Ub measured in both the nucleus and cytoplasm of co-transfected NSC-34 cells. Data shown are means±s.e.m.
(n≥6, combined from three independent experiments). (D) Quantification of the proportion of mobile Ub in the nucleus and cytoplasm of cells expressing either
SOD1WT, soluble SOD1A4V or insoluble SOD1A4V. Data shown are means±s.e.m. combined from three independent experiments (n≥7). One-way ANOVA with a
Tukey’s multiple comparison post-test was used to compare differences, which were not significant.

Ub distribution and mobility are not significantly altered in
cells containing SOD1A4V aggregates

Ub exists in a dynamic equilibrium in the cell, partitioning into four
major pools: (1) immobile in the nucleus, (2) immobile in the
cytoplasm, (3) soluble polyUb chains, and (4) a small fraction as
free monomeric Ub (Dantuma et al., 2006). Mobile Ub is a
combination of free monomeric Ub, free Ub chains and Ub attached
to diffusible proteins (Fig. S1). Immobile Ub is primarily bound to
histones in the nucleus, and bound to organelles and cytoskeleton in
the cytoplasm (Fig. S1). To determine whether the observed UPS
dysfunction in cells with mutant SOD1 aggregates was associated
with altered Ub homeostasis, we examined the distribution of Ub
into different cellular pools following expression of wild-type or
mutant SOD1A4V by fluorescence recovery after photobleaching
(FRAP) (Fig. 3A–D). The diffusion rate back into the bleached area
provides information on the mobility of the Ub species present in
4
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significant overlap between the two populations, so we could
not entirely distinguish populations. We decided to analyse the
most highly fluorescent cells (top 10%) across the entire population.
In this subset of cells, ∼80% contained SOD1A4V inclusions
(Fig. 2D). We reasoned that analysing the top 10% fluorescent cells
would sufficiently enrich for cells containing inclusions. Using flow
cytometry, we observed a 4-fold increase in reporter fluorescence
(P<0.001) – indicating UPS dysfunction – in the top 10% of
SOD1A4V–GFP-expressing cells compared to control cells
(expressing SOD1WT) in the same fluorescence range. That is, UPS
dysfunction in SOD1A4V cells is largely restricted to cells containing
aggregates. By comparison, only a small increase (1.2-fold) in reporter
fluorescence was observed in the entire population of SOD1A4V–
GFP-expressing cells compared with the entire SOD1WT–GFPexpressing population (P<0.01) (Fig. 2E). This suggests that SOD1
aggregation is associated with compromised UPS function.

solution and the amount of immobile fluorophore in the
compartment of interest (i.e. bound to membrane vesicles or
cytoskeleton in the cytosol, and bound to histones in the nucleus).
We selected regions of interest (ROIs) in both the nucleus and
cytoplasm (Fig. 3B) in cells co-expressing mCherry–Ub and GFP,
SOD1WT–GFP or SOD1A4V–GFP. In the case of SOD1A4V–GFPexpressing cells, we performed the analysis on two subpopulations,
cells with and without aggregates. As previously reported (Dantuma
et al., 2006), we find that Ub FRAP (indicating Ub mobility) is
higher in the cytoplasm than in the nucleus, likely due to a large
proportion of nuclear Ub being attached to histones. Patterns of
recovery appeared to be similar in all treatments, with the exception
of a lower cytoplasmic recovery in the cells containing SOD1A4V–
GFP aggregates (Fig. 3A). After calculating the mean half-life (T1/2)
of recovery in each case, we find no significant differences between
any of the cell populations (Fig. 3C). This suggests that, within the
mobile population of Ub, the presence of SOD1A4V–GFP
aggregates does not significantly alter the kinetics of Ub
diffusion. Furthermore, the amount of mobile Ub available to the
cell did not appear to be altered by the presence of aggregates, as no
significant differences in the mobility of Ub were observed between
cells containing SOD1A4V aggregates and the controls (Fig. 3D).
Free monomeric Ub is lowered in cells with SOD1A4V
aggregates

To test whether cells containing SOD1A4V–GFP aggregates may
diminish free monomeric Ub, we next examined the relative
amounts of monomeric Ub in cells expressing GFP, SOD1WT–GFP
or SOD1A4V–GFP for 48 h, by western blotting (Fig. 4A). We did
not observe any significant differences using this method, likely due
to the fact that this analysis represents a total measure of all cells in
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the culture, including non-transfected cells (Fig. S5). We therefore
turned to fluorescence recovery after nucleus photobleaching
(FRANP) analysis to monitor free Ub in single cells. Monomeric
mCherry–Ub will diffuse through the nuclear pore (<60 kDa), while
mCherry–Ub incorporated into Ub chains will not (Dantuma et al.,
2006). Hence, relative free monomeric Ub can be measured
by monitoring diffusion through the nuclear pore following
fluorescence bleaching solely in the nucleus or cytosol (Dantuma
et al., 2006). We transfected cells with GFP, SOD1WT–GFP or
SOD1A4V–GFP (Fig. 4B) for 48 h, then bleached the entire nucleus
and quantified the amount of relative monomeric Ub diffusing
through the nuclear pore back into the nucleus (Fig. 4C). We
observed a significant drop in free monomeric Ub in cells
containing SOD1A4V–GFP aggregates, but no difference in the
level of monomeric Ub between cells expressing SOD1WT and
SOD1A4V in the absence of inclusions (Fig. 4D).
SOD1A4V–GFP induces changes in the ubiquitome of NSC34
cells

Free Ub exists in complex equilibrium with multiple conjugated
forms, and ALS mutations may induce redistribution of Ub through
altered activity in various cellular pathways. To investigate changes
in the Ub-modified proteome (the ‘ubiquitome’) of cells expressing
SOD1WT compared with SOD1A4V–GFP, we performed proteomics
following enrichment of cell lysates for ubiquitylated proteins
(Fig. 5A). We identified 316 ubiquitylated proteins common to cells
expressing either SOD1WT or SOD1A4V; 55 proteins were uniquely
present in the ubiquitome of cells expressing SOD1A4V and 11
unique proteins were identified in the ubiquitome of cells expressing
SOD1WT (Fig. 5B; Table 1). Network analysis of known protein–
protein interactions and ontology in the set of ubiquitylated proteins

Fig. 4. Reduced levels of free monomeric Ub in NSC-34 cells containing SOD1A4V aggregates. (A) Western blot analysis of cell lysates of NSC-34 cells transiently
transfected with SOD1WT–GFP or SOD1A4V–GFP, mRFP–Ub or Turbo (t)GFP control. UT, not transfected. Samples were separated under reducing conditions and
probed with anti-Ub antibody. (B) The entire nucleus of co-transfected NSC-34 cells was photobleached and the recovery of nuclear Ub was monitored as a proportion
of cytoplasmic fluorescence for 120 s. Data shown are means±s.e.m. (n≥17) combined from three independent experiments. Cells expressing SOD1A4V were
classified according to whether SOD1A4V was either soluble (s) or insoluble (i). (C) Representative confocal images of pre-bleach, post-bleach and final read. (D) The
percentage of mobile Ub in the nucleus at the final read was quantified as a proportion of cytoplasmic fluorescence. Data represent mean±s.e.m. (n≥17, combined from
three independent experiments). *P<0.05; **P<0.01; ***P<0.001 (one-way ANOVA with a Tukey’s comparison post test). Scale bars: 10 µm.
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Fig. 5. The ubiquitylated proteome of transfected NSC-34 cells. (A) NSC-34 cells expressing GFP fusions of SOD1WT or SOD1A4V were subjected to
high-affinity purification to isolate ubiquitylated proteins, which were subsequently identified by LC-MS/MS. (B) Venn analysis comparing the number of
ubiquitylated proteins in NSC-34 cells transfected with either SOD1A4V (n=2) or SOD1WT (n=3). (C) STRING analysis of the protein–protein interaction network of
ubiquitylated proteins unique to cells expressing SOD1A4V or SOD1WT. Proteins were identified as present in each condition if they were present in at least
two replicates for that condition. Additionally proteins were only considered ‘unique’ to either SOD1WT or SOD1A4V if they were not identified in any of the
replicates for any of the other conditions. (D) The median supersaturation score calculated for the unfolded (σu) and native (σf ) states of proteins unique to
the SOD1A4V ubiquitome (Ubiq). Fold Δ refers to the increase in supersaturation score from the known mouse proteome (Prt). The box represents the 25–75th
percentiles, and the median is indicated. The whiskers range from the lowest to highest value data points within 150% of the interquartile ranges. Statistical
significance was assessed by the one-sided Wilcoxon/Mann–Whitney U-test with Holm–Bonferroni-corrected P values (****P<0.0001).

instability and resulting redeployment of Ub, driving altered Ub
distribution and subsequent impairment of Ub homeostasis upon
expression of a chronically misfolded protein.
Cells with SOD1A4V aggregates have altered mitochondrial
morphology and function

Previous work has shown that mutations in SOD1 lead to
mitochondrial dysfunction (Mattiazzi et al., 2002; Vande Velde
et al., 2011; Song et al., 2013; Joshi et al., 2018). Our ubiquitome
analysis (above) identified enrichment of mitochondrial/metabolic
proteins in the ubiquitome of SOD1A4V-expressing cells (Table 1),
suggesting potential mitochondrial defects in these cells. Hence, we
labelled mitochondria with Mitotracker and examined morphology
using confocal microscopy (Fig. 6A–C). We found that SOD1A4Vexpressing cells contained a significantly higher number of
mitochondria per cell compared to controls (Fig. 6B). In addition,
6
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unique to cells expressing mutant SOD1A4V using the String
database (Szklarczyk et al., 2015) identified a number of enriched
pathways, including metabolic pathways, the ubiquitin-proteasome
system (UPS), and ribosome and mRNA processing and transport
(Fig. 5C). Expression of a chronic misfolded protein has previously
been observed to increase proteome misfolding and we have shown
that ALS aggregates are composed of supersaturated proteins – that is,
proteins which have expression levels higher than one might predict
given their solubility (Ciryam et al., 2017).
We compared the supersaturation scores for both the unfolded
and native states of ubiquitylated proteins found uniquely in
SOD1A4V–GFP-expressing cells to those of the whole proteome.
The median supersaturation score of these 55 ubiquitylated proteins
is 10× higher than that for the whole proteome in the unfolded state
(σu) and 25× higher than that for the whole proteome in the native
state (σf ) (Fig. 5D). These data are consistent with proteome
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Table 1. Components of the ubiquitin-modified proteome (ubiquitome) identified uniquely in cells expressing either SOD1WT or mutant SOD1A4V
Entry name

Unique to SOD1A4V
P14206
RSSA_MOUSE
P47753
CAZA1_MOUSE
Q91V12
BACH_MOUSE
Q9QUR6
PPCE_MOUSE
Q922D8
C1TC_MOUSE
P45376
ALDR_MOUSE
Q8CGZ0
Q8R081
O08784
O09061
O54734

CHERP_MOUSE
HNRPL_MOUSE
TCOF_MOUSE
PSB1_MOUSE
OST48_MOUSE

P29341
P35564
P62492
P54729
P56135
P56959
Q7TPR4
P61957
P62717
P80314
P84099
Q0VGU4
Q3THS6
Q3TIU4
Q3U2C5
Q60692
Q61074
Q61081
Q61990
Q62318

PABP1_MOUSE
CALX_MOUSE
RB11A_MOUSE
NUB1_MOUSE
ATPK_MOUSE
FUS_MOUSE
ACTN1_MOUSE
SUMO2_MOUSE
RL18A_MOUSE
TCPB_MOUSE
RL19_MOUSE
Q0VGU4_MOUSE
METK2_MOUSE
PDE12_MOUSE
RN149_MOUSE
PSB6_MOUSE
PPM1G_MOUSE
CDC37_MOUSE
PCBP2_MOUSE
TIF1B_MOUSE

Q64514
Q8QZT1
Q8VCN5
Q8VDW0
Q7TMK9

TPP2_MOUSE
THIL_MOUSE
CGL_MOUSE
DX39A_MOUSE
HNRPQ_MOUSE

Q91YQ5

RPN1_MOUSE

P17225
Q99LX5
Q9CQ60
Q9CRB9
Q9CWF2
Q9CWJ9
Q9CZ13

PTBP1_MOUSE
MMTA2_MOUSE
6PGL_MOUSE
MIC19_MOUSE
TBB2B_MOUSE
PUR9_MOUSE
QCR1_MOUSE

Q9D0E1
HNRPM_MOUSE
Q9D0M3
CY1_MOUSE
Q9DCH4
EIF3F_MOUSE
Q9DCL9
PUR6_MOUSE
Q9JJI8
RL38_MOUSE
Q9JM13
RABX5_MOUSE
Q9JMH6
TRXR1_MOUSE
Q9QZD9
EIF3I_MOUSE
Q9WU78
PDC6I_MOUSE
Q9Z1Z2
STRAP_MOUSE
Q9Z2X1
HNRPF_MOUSE
Unique to SOD1WT
B2RY56
RBM25_MOUSE
P51410
RL9_MOUSE
P04370
MBP_MOUSE

Unique
peptides

Protein names

Gene names

40S ribosomal protein SA
F-actin-capping protein subunit alpha-1
Cytosolic acyl coenzyme A thioester hydrolase
Prolyl endopeptidase
C-1-tetrahydrofolate synthase
Aldose reductase

Rpsa, Lamr1, P40-8
Capza1, Cappa1
Acot7, Bach
Prep, Pep
Mthfd1
Akr1b1, Akr1b3, Aldor1,
Aldr1
Cherp, Scaf6
Hnrnpl, Hnrpl
Tcof1
Psmb1
Ddost

5
3
3
4
2
4

Pabpc1, Pabp1
Canx
Rab11a, Rab11
Nub1, Nyren18
Atp5j2
Fus
Actn1
Sumo2, Smt3b, Smt3h2
Rpl18a
Cct2, Cctb
Rpl19
Vgf, mCG_18019
Mat2a
Pde12
Rnf149, Greul4
Psmb6, Lmp19
Ppm1 g, Fin13, Ppm1c
Cdc37
Pcbp2, Cbp, Hnrnpx, Hnrpx
Trim28, Kap1, Krip1, Tif1b

4
5
2
2
2
3
5
2
4
6
2
4
2
2
2
3
3
2
2
4

Tpp2
Acat1
Cth
Ddx39a, Ddx39
Syncrip, Hnrpq, Nsap1,
Nsap1l
Rpn1

2
2
3
2
3

Calcium homeostasis endoplasmic reticulum protein
Heterogeneous nuclear ribonucleoprotein L
Treacle protein
Proteasome subunit beta type-1
Dolichyl-diphosphooligosaccharide–protein glycosyltransferase
48 kDa subunit
Polyadenylate-binding protein 1
Calnexin
Ras-related protein Rab-11A
NEDD8 ultimate buster 1
ATP synthase subunit f, mitochondrial
RNA-binding protein FUS
Alpha-actinin-1
Small ubiquitin-related modifier 2
60S ribosomal protein L18a
T-complex protein 1 subunit beta
60S ribosomal protein L19
VGF nerve growth factor inducible
S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2)
2′,5′-phosphodiesterase 12 (2′-PDE) (2-PDE)
E3 ubiquitin-protein ligase RNF149
Proteasome subunit beta type-6
Protein phosphatase 1G
Hsp90 co-chaperone Cdc37
Poly(rC)-binding protein 2 (Alpha-CP2)
Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein
ligase TRIM28)
Tripeptidyl-peptidase 2 (TPP-2)
Acetyl-CoA acetyltransferase, mitochondrial
Cystathionine gamma-lyase
ATP-dependent RNA helicase DDX39A
Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q)

3
2
2
2
4

Dolichyl-diphosphooligosaccharide–protein glycosyltransferase
subunit 1
Polypyrimidine tract-binding protein 1 (PTB)
Multiple myeloma tumor-associated protein 2 homolog
6-phosphogluconolactonase (6PGL)
MICOS complex subunit Mic19
Tubulin beta-2B chain
Bifunctional purine biosynthesis protein PURH
Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III
subunit 1)
Heterogeneous nuclear ribonucleoprotein M
Cytochrome c1, heme protein, mitochondrial (Complex III subunit 4)
Eukaryotic translation initiation factor 3 subunit F
Multifunctional protein ADE2
60S ribosomal protein L38
Rab5 GDP/GTP exchange factor
Thioredoxin reductase 1, cytoplasmic
Eukaryotic translation initiation factor 3 subunit I
Programmed cell death 6-interacting protein
Serine-threonine kinase receptor-associated protein
Heterogeneous nuclear ribonucleoprotein F

5

Ptbp1, Ptb
Mmtag2
Pgls
Chchd3, Mic19
Tubb2b
Atic, Purh
Uqcrc1

4
2
5
3
3
4
4

Hnrnpm, Hnrpm
Cyc1
Eif3f, Eif3s5
Paics
Rpl38
Rabgef1, Rabex5
Txnrd1, Trxr1
Eif3i, Eif3s2, Trip1
Pdcd6ip, Aip1, Alix
Strap, Unrip
Hnrnpf, Hnrpf

3
3
4
5
3
3
2
4
4
2
3

RNA-binding protein 25
60S ribosomal protein L9
Myelin basic protein

Rbm25
Rpl9
Mbp, Shi

2
5
4
Continued
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Table 1. Continued
Entry name

Protein names

Gene names

P43276
P62911
P63166

H15_MOUSE
RL32_MOUSE
SUMO1_MOUSE

Histone H1.5
60S ribosomal protein L32
Small ubiquitin-related modifier 1 (SUMO-1)

P97350
Q60932
Q6ZQ38

PKP1_MOUSE
VDAC1_MOUSE
CAND1_MOUSE

Plakophilin-1
Voltage-dependent anion-selective channel protein 1 (VDAC-1)
Cullin-associated NEDD8-dissociated protein 1

Q7TSF1
Q9Z315

DSG1B_MOUSE
SNUT1_MOUSE

Desmoglein-1-beta
U4/U6.U5 tri-snRNP-associated protein 1

Hist1h1b, H1f5
Rpl32
Sumo1, Smt3c, Smt3h3,
Ubl1
Pkp1
Vdac1, Vdac5
Cand1, D10Ertd516e,
Kiaa0829
Dsg1b, Dsg5
Sart1, Haf

these mitochondria are significantly more circular than those in
control cells (Fig. 6C). We quantified Mitotracker fluorescence in
cells by using flow cytometry, as above focusing on the top 10%
most fluorescent cells (based on SOD1–GFP expression) to enrich
for cells with aggregates (i.e. when expressing SOD1A4V). This
subset of SOD1A4V-expressing cells has higher Mitotracker
fluorescence compared to SOD1WT-expressing cells exhibiting the
same level of fluorescence – consistent with accumulation of
mitochondria seen upon SOD1A4V expression (Fig. 6D). In the
same subset of aggregate-containing cells, we observed increased
fluorescence of the functional reporter CMXRos, suggesting
alterations in mitochondrial membrane potential (Fig. 6E).
DISCUSSION

A unifying feature of neurodegenerative diseases such as ALS is the
presence of Ub within insoluble protein aggregates (Leigh et al., 1991;

Unique
peptides
3
3
2
17
8
2
6
2

Lowe et al., 1988; Mori et al., 1987). Beyond labelling substrates for
degradation via the proteasome, Ub is an important regulator of
cellular processes such as transcription, translation, endocytosis and
DNA repair. The sequestration of Ub into inclusions may therefore
reduce the availability of free Ub essential for these processes,
compromising cellular function and survival. To gain insight into the
regulation of Ub homeostasis in ALS, we followed the dynamic
distribution of Ub at a single-cell level in a well-established SOD1
cell model of ALS. Our results confirm that the expression of mutant
SOD1A4V leads to UPS dysfunction and corresponding disruption of
Ub homeostasis, suggesting these processes plays a key role in the
development of ALS pathology.
In cell models, Ub regulates the concentrations of TDP-43 and
SOD1 (Scotter et al., 2014; Miyazaki et al., 2004), and proteasome
inhibition can trigger their abnormal accumulation. While our
previous work has established that SOD1 aggregates contain Ub
Fig. 6. Cells containing SOD1A4V aggregates
display altered mitochondrial morphology and
dysfunction. (A) NSC-34 cells transiently
transfected with SOD1WT–GFP or SOD1A4V–GFP
(or tGFP as a control) were stained for mitochondria
with Mitotracker Deep Red at 48 h post transfection.
Scale bars: 10 µm. The number of mitochondria (B)
and their circularity (C) was determined using a
mitochondrial morphology macro in ImageJ. Data
represent mean±s.e.m. (n≥23). (D) Mitotracker
fluorescence was also quantified by flow cytometry
in cells expressing the highest levels of SOD1WT–
GFP or SOD1A4V–GFP. (E) Mitochondrial
membrane potential was examined through the
accumulation of Mitotracker Red CMXRos. Data
represent mean±s.e.m. (n=3). *P<0.05; **P<0.01;
***P<0.001 (one-way ANOVA with a Tukey’s multiple
comparison post test).
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(Farrawell et al., 2015), results here confirm that SOD1 coaggregates with Ub, and that Ub is present at the earliest stage of
aggregation. Furthermore, SOD1 aggregates were found to contain
both K48- and K63-linked polyubiquitin chains, which signal
degradation via the proteasome and autophagy pathways,
respectively (Kwon and Ciechanover, 2017). Interestingly, both
K48- and K63-linked ubiquitylation has been associated with the
formation of inclusions (Tan et al., 2008), with previous studies
showing that K63 polyubiquitylation directs misfolded SOD1 to the
ubiquitin-aggresome route when the UPS is inhibited (Wang et al.,
2012). These data are consistent with the need for tightly regulated
Ub homeostasis in neurons, and suggest that any perturbation in this
homeostasis could cause Ub depletion and subsequent toxicity. It is
likely that protein aggregation causes Ub depletion, which could
then drive further aggregation in a positive-feedback loop (Fig. 7).
In the nervous system, the UPS contributes to the regulation of
many aspects of synaptic function, such as neuronal growth and
development, neuronal excitability, neurotransmission, long-term
potentiation (LTP) and synapse formation and elimination (Mabb
and Ehlers, 2010; Kawabe and Brose, 2011). UPS dysfunction is
therefore central to neuronal health and neurodegenerative disease
(Yerbury et al., 2016). Impairment of the UPS has been implicated
strongly in the pathogenesis of ALS (Scotter et al., 2014; Tashiro
et al., 2012; Cheroni et al., 2009). Here, we reveal that the
aggregation of SOD1 compromises UPS function, decreasing
cellular capacity to degrade the proteasome reporter tdTomatoCL1.
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Our findings are consistent with the previous demonstration of UPS
dysfunction in ALS, with accumulation of the fluorescent UPS
reporter UbG76V–GFP observed in the spinal cord and cranial motor
neurons of SOD1G93A mice (Cheroni et al., 2009). Moreover, a
motor neuron-specific knockdown of the proteasome subunit Rpt3
in the absence of ALS genetic background results in an ALS
phenotype in mice – including locomotor dysfunction, progressive
motor neuron loss and mislocalisation of ALS markers TDP-43,
FUS, ubiquilin 2 and optineurin (Tashiro et al., 2012). These data
support a model where a reduction in UPS capacity is sufficient to
drive ALS pathology in mice. Not even overexpression of human
mutant TDP-43 gives such an accurate reproduction of a human
ALS-like phenotype in mice. In ALS patient spinal motor neurons,
85% (38/40) of cytoplasmic TDP-43 foci or inclusions were
positive for Ub. In fact, almost all cellular Ub in these neurons was
sequestered within large skein-like inclusions (Farrawell et al.,
2015). Interestingly, Ub has been found to accumulate in inclusions
without the aggregation of TDP-43 in sALS (Giordana et al., 2010),
suggesting that aggregation of proteins, such as TDP-43, FUS and
SOD1 may not be necessary for Ub depletion-induced toxicity. In
human skin fibroblasts, it has been shown that the UPS reporter
GFPCL1 accumulates significantly more in ALS patient fibroblasts
compared to controls, suggesting a compromised UPS (Yang et al.,
2015). This raises the question of whether there are alternative
means to control protein concentration when protein aggregates
disrupt degradation mechanisms. It was recently proposed that

Fig. 7. Disrupted Ub homeostasis in ALS. Mutations in SOD1-associated ALS disrupt Ub homeostasis, either directly or through sequestration of Ub into protein
aggregates. These changes result in altered Ub distribution and subsequent depletion of free Ub, eventually reaching a threshold below which vital cellular
functions are severely compromised, and ultimately result in cell death.
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widespread transcriptional repression may serve this purpose in
Alzheimer’s disease (Ciryam et al., 2016).
The work presented here suggests that the aggregation of
misfolded SOD1 alters Ub homeostasis and subsequently depletes
the free Ub pool in cells. Cellular Ub exists in a complex equilibrium
between free and conjugated Ub (Dantuma et al., 2006). Neurons
are vulnerable to a deficiency in free Ub, which, if prolonged, can
lead to cell death (Tan et al., 2000, 2001). Many factors can
influence Ub homeostasis. For example, proteasome inhibition
depletes free Ub to as low as 5% of basal levels in less than 2 h
(Mimnaugh et al., 1997; Patnaik et al., 2000). Inhibition of
translation also depletes free Ub through reduced production, while
toxicity can be rescued by overexpression of Ub (Hanna et al.,
2003). Accumulation of ubiquitylated proteins in inclusions is an
important potential mechanism for depletion of free Ub, and, in this
context, free Ub levels can be partially restored by overexpression or
removal of Ub from the aggregated protein through ubiquitinspecific proteases. It was recently shown that while the ataxiaassociated mutation in Usp14 causes a reduction in free Ub and
neuromuscular junction dysfunction in mice, overexpression of Ub
restored free Ub levels in motor neurons and improved the
neuromuscular junction (NMJ) structure (Vaden et al., 2015).
Additionally, free Ub could be increased in cells containing
huntingtin aggregates by overexpression of the de-ubiquitylation
enzyme USP14 (Hyrskyluoto et al., 2014). Not only did this protect
cells from aggregate-induced toxicity, it also reduced ER stress,
which is thought to precede inclusion formation in ALS models
(Atkin et al., 2014). Furthermore, perturbations in ubiquitin
homeostasis caused by dysregulation of ubiquitin-like modifier
activating enzyme 1 (UBA1) induces neuromuscular pathology in
animal models of spinal muscular atrophy (Wishart et al., 2014;
Powis et al., 2016). Systemic restoration of UBA1 has been shown
to rescue this pathology (Powis et al., 2016). These data further
support the concept that modulation of cellular Ub pools is an
important factor in the pathogenesis of neurodegenerative disease.
The pathways responsible for modulating Ub homeostasis in ALS
are not yet well understood. Our ubiquitomics analysis of cells
expressing SOD1 reveals that the unique ubiquitome of cells
expressing SOD1A4V is enriched for proteins prone to aggregation
(i.e. that are supersaturated). This is consistent with findings that
proteins associated with neurodegeneration are supersaturated (Ciryam
et al., 2013, 2015, 2017). Furthermore, a substantial proportion of the
ubiquitylated proteins identified are from pathways known to be
dysfunctional in ALS, including RNA processing, and metabolic and
mitochondrial pathways. This is not surprising given that both RNAbinding proteins and oxidative phosphorylation and metabolic
pathways are also prone to aggregation in neurodegeneration
(Ciryam et al., 2015). These results suggest that mutations in SOD1
may lead to mitochondrial dysfunction by disrupting Ub homeostasis.
Interestingly, we find that cells expressing mutant SOD1A4V had
altered mitochondrial morphology and function. Disturbances to
mitochondrial morphology and function have been previously
reported in human motor neurons carrying the SOD1A4V mutation
(Kiskinis et al., 2014) and NSC-34 cells expressing mutant SOD1G93A
(Joshi et al., 2018). Recent studies have revealed that mitochondrial
impairment occurs soon after proteasome inhibition (Maharjan et al.,
2014). In fact, continued proteasome dysfunction in mouse brain
cortical neurons inhibited the degradation of ubiquitylated
mitochondrial proteins and led to the accumulation of dysfunctional
mitochondria (Ugun-Klusek et al., 2017). Misfolded proteins such as
mutant SOD1 have also been shown to interact with mitochondrial
proteins and translocate into the mitochondrial intermembrane space
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and mitochondrial matrix, where they accumulate and induce
mitochondrial dysfunction (Vijayvergiya et al., 2005; Jaarsma et al.,
2001; Ruan et al., 2017; Igoudjil et al., 2011; Fischer et al., 2011).
However, this cytotoxicity can be attenuated through the
ubiquitylation of misfolded but non-aggregated SOD1, which
promotes its degradation via the UPS (Yonashiro et al., 2009).
Collectively, these studies demonstrate an integral functional
relationship between impairment of the UPS and mitochondrial
dysfunction, and that modulation of cellular Ub pools may rescue
mitochondrial dysfunction caused by the accumulation of SOD1.
Conclusions

In conclusion, we observe that the aggregation of mutant SOD1A4V
leads to altered UPS activity and redistribution of Ub, causing
disrupted Ub homeostasis. Given that Ub controls many essential
cellular pathways that are also dysfunctional in ALS – including
transcription, translation, vesicle transport, mitochondrial function
and apoptosis – these findings suggest that Ub homeostasis is a
central feature of ALS pathogenesis. Further understanding of the
contribution of Ub homeostasis to ALS pathology may be
imperative to understanding the molecular pathways underpinning
neurodegenerative disease more broadly.
MATERIALS AND METHODS
Plasmids

pEGFP-N1 vectors containing human SOD1WT and SOD1A4V were
generated as described previously (Turner et al., 2005). The tGFP
construct ( pCMV6-AC-GFP) was obtained from OriGene (USA). GFP–
Ub and mRFP–Ub (Addgene plasmids 11928 and 11935, deposited by
Nico Dantuma; Dantuma et al., 2006; Bergink et al., 2006) were acquired
from Addgene. The mCherry–Ub construct was created by replacing
the mRFP sequence in mRFP–Ub with mCherry fluorescent protein. The
tdTomatoCL1 construct was obtained by cloning the CL1 sequence
(ACKNWFSSLSHFVIHL) into pcDNA3.1(+)tdTomato.
Cell culture and transfection

Neuroblastoma×spinal cord hybrid NSC-34 cells (Cashman et al., 1992) were
maintained in Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient
Mixture F12 (DMEM/F12) supplemented with 10% fetal bovine serum
(FBS, Bovogen Biologicals, Australia). Cells were maintained at 37°C in a
humidified incubator with 5% atmospheric CO2. For confocal microscopy,
cells were grown on 13 mm round coverslips in 24-well plates or on eight-well
µ-slides (Ibidi, Germany). Cells were grown in six-well plates for cell lysate
and cell sorting experiments. Cells were transfected using Lipofectamine
3000 (Invitrogen, USA) according to manufacturer’s instructions with 0.5 μg
DNA per well for a 24-well plate, 0.2 μg DNA per well for eight-well µ-slides
and 2.5 μg DNA per well for six-well plates. For co-transfections the amount
of DNA was divided equally between constructs. Animal studies were
performed with the approval (AE11/29 and AE12/09) of the Animal Ethics
Committee of the University of Wollongong (Wollongong, Australia).
Measurement of UPS function

To quantify UPS activity, NSC-34 cells were co-transfected with the
fluorescent proteasome reporter tdTomatoCL1 and treated overnight (∼18 h)
with 0–30 µM of the proteasome inhibitor MG132. The level of tdTomatoCL1
fluorescence was determined via flow cytometry on a Becton Dickinson flow
cytometer 48 h post transfection as in Yang et al. (2015).
Live cell imaging

Imaging of NSC-34 cells co-transfected with SOD1A4V–GFP and
mRFP–Ub was performed 24 h post transfection on a Leica TCS SP5
confocal microscope. Cells were imaged every 15 min over 17 h in a CO2
chamber maintained at 37°C with 5% CO2. For fluorescence recovery
after photobleaching (FRAP) and fluorescence recovery after nucleus
photobleaching (FRANP) experiments, analysis was performed on
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transfected NSC-34 cells at 48 h post transfection using the LAS AF FRAP
Application Wizard on the Leica TCS SP5 confocal microscope. Images were
acquired using the 63× objective with two line averages and a scan speed of
700 Hz. Five pre-bleach images were acquired over 7.5 s with the 561 nm
laser set at 20% power. The region of interest (ROI) was then bleached using
the ‘zoom in ROI’ method over five frames of 1.5 s at 100% laser power. For
FRANP analysis, the entire nucleus was bleached. Fluorescence recovery or
loss was monitored for 120 s with the laser power set back at 20%.
To quantify SOD1 inclusion formation, images were acquired as
described previously (McAlary et al., 2016). Briefly, z-stack images of
NSC-34 cells transfected with SOD1–GFP constructs were acquired at 48 h
post transfection using the 63× objective, 512×512 pixels, one line and
frame average, and a scan speed of 400 Hz. z-stacks were processed into a
single image using LAS-AF Lite software (Leica) and at least 100
transfected cells were analysed for the presence of inclusions.
Frequency distribution analysis

GFP fluorescence in NSC-34 cells expressing soluble and insoluble
(aggregated) SOD1A4V–GFP was quantified from confocal images taken
48 h post transfection using ImageJ 1.48v (Schneider et al., 2012). A
minimum of 100 transfected cells were analysed per experiment. Frequency
distribution analysis was subsequently performed in GraphPad Prism
version 5.00 for Windows (GraphPad software, USA).
Toxicity assay

The viability of cells expressing SOD1 was monitored over 68 h in an
Incucyte automated fluorescent microscope (Essen BioScience, USA) as
described in McAlary et al. (2016). Cells were dissociated at 24 h post
transfection and re-plated in 96-well plates at a confluency of 20% in
Phenol-Red-free DMEM/F12 containing 10% FBS. Images were acquired
every 2 h and analysed using a processing definition trained to select GFPpositive cells. The number of GFP-positive cells was normalised to time
zero before SOD1A4V numbers were normalised to SOD1WT values.
Immunofluorescence

NSC-34 cells grown on coverslips were transfected with GFP-tagged
SOD1A4V and fixed for 20 min at room temperature (RT) with 4%
paraformaldehyde (PFA) (Merck Millipore, USA) in phosphate-buffered
saline (PBS) 48 h post transfection. Cells were permeabilised in 1% Triton
X-100 (TX-100) in PBS for 30 min on ice before blocking for 1 h at RT with
5% FBS, 1% bovine serum albumin (BSA) 0.3% TX-100 in PBS. Cells
were incubated with rabbit primary antibodies against K48 or K63 Ub chain
linkages (05-1307/05-1308, Merck Millipore; 1:500 dilution) overnight at
4°C followed by Alexa Fluor 647-conjugated anti-rabbit-IgG secondary
antibody (ab150079, Abcam, UK; 1:500 dilution) for 5 h at RT. All
antibodies were diluted in 1% BSA, 0.1% TX-100 in PBS and cells were
washed with PBS between each incubation step.
Spinal cord sections from the SOD1G93A mouse were also stained for SOD1
and K48 or K63 Ub chain linkages. A pap pen (Daido Sangyo, Tokyo, Japan)
was used to separate tissue sections mounted onto the same slide. Sections
were then fixed with 4% PFA for 15 min at RT before permeabilisation at RT
for 10 min with 0.1% TX-100 in PBS containing 2% (v/v) normal horse
serum (NHS). Sections were then blocked for 20 min at RT with 20% NHS
and 2% BSA in PBS followed by staining overnight at 4°C in a humidified
chamber with sheep anti-SOD1 (ab8866, Abcam; 1:200 dilution), mouse
neuron-specific βIII tubulin antibody (ab78078, Abcam; 1:200 dilution) and
rabbit anti-ubiquitin K48 or K63 (Merck Millipore; 1:200 dilution). The
following day, sections were incubated with 4 µg/ml Alexa Fluor-conjugated
secondary antibodies reactive to sheep, mouse and rabbit IgG (A21100,
Invitrogen; ab150114, Abcam; A181448, Invitrogen) for 1 h at RT. Following
staining, coverslips were mounted onto slides using ProLong Diamond
Antifade Mountant (Molecular Probes). All imaging experiments were
performed on a Leica TCS SP5 confocal microscope.
Cell lysis

NSC-34 cells grown in six-well plates and transfected with SOD1–GFP or
mRFP–Ub were harvested 48 h post transfection with trypsin-EDTA
(Gibco). Cells were washed with PBS before being resuspended in RIPA
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buffer [50 mM Tris-HCl pH 7.4, 1% (w/v) sodium deoxycholate, 150 mM
NaCl, 1 mM EDTA, 1% TX-100, 0.1% SDS, 10 mM NEM, 1 mM sodium
orthovanadate, HaltTM Protease Inhibitor Cocktail (Thermo Scientific)].
Protein concentration was determined with a BCA assay.
Western blotting

Cell lysates with a total protein concentration of 100 µg were reduced with
β-mercaptoethanol and heated for 10 min at 70°C before being analysed
on a Mini-PROTEAN TGX Stain-Free Gel (Bio-Rad) for 2 h at 100 V.
Proteins were transferred onto a nitrocellulose membrane (Pall Corporation)
using the standard protocol on the Bio-Rad Trans-Blot Turbo Transfer
System. The membrane was blocked in 5% skim milk powder in Tris-buffered
saline with 0.2% (v/v) Tween-20 (TBST) for 1 h at RT before probing for Ub
with rabbit anti-Ub antibody (ab137025, Abcam; 1:1500 dilution) overnight
at 4°C. The following day the membrane was washed three times with TBST
over 30 min before incubating with horseradish peroxidise (HRP)-conjugated
anti-rabbit-IgG antibody (1706515, Bio-Rad; 1:2000 dilution) for 1 h at RT.
The membrane was visualised with chemiluminescent substrate (Thermo
Scientific) on the Amersham Imager 6600RGB.
Cell sorting

NSC-34 cells transfected with SOD1WT-GFP or SOD1A4V–GFP were
harvested 24 h post transfection with trypsin-EDTA (Gibco) and washed
with PBS before being resuspended in Phenol Red-free medium containing
10% FBS and filtered through a 35 µm nylon mesh strainer (Greiner BioOne, Austria). Enrichment of GFP-positive cells was performed on a FACS
Aria III (BD Biosciences, USA) and a BD FACs Aria II (BD Biosciences).
Cells were sorted based on GFP fluorescence (excitation 488 nm, emission
530/30 nm) and collected into 5 ml FACS tubes containing 1 ml FBS.
Following enrichment, cells were lysed for ubiquitomics analysis.
Ubiquitomics

Proteomics to identify the ubiquitin-modified proteome (the ‘ubiquitome’)
in NSC-34 cells was performed as described in Nagarajan et al. (2017). Cells
were lysed in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5%
NP-40, 1 mM DTT, 1× EDTA-free protease inhibitor cocktail, 10 mM
N-ethylmaleimide, 1 mM sodium orthovanadate). Protein concentration was
determined using a BCA assay, and 300 µg of total protein was used per sample
to immunopurify mono- and poly-ubiquitylated proteins using 30 µl of
VIVAbind Ub affinity matrix (Ubiquitin Kit, VIVA Bioscience). Samples were
incubated for 2 h at 4°C with end-to-end mixing then matrix was collected by
centrifugation (1 min; 4°C; 1000 g) and washed six times in 500 µl of detergentfree wash buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DTT, 1x
EDTA-free protease inhibitor cocktail, 10 mM N-ethylmaleimide, 1 mM
sodium orthovanadate]. After washing, beads were digested for 30 min at 27°C,
then reduced with 1 mM DTT and left to digest overnight at RT with
sequencing-grade trypsin (5 µg/ml, Promega), as described previously
(Turriziani et al., 2014). Samples were alkylated with 5 mg/ml iodoacetamide,
and protease digestion terminated with trifluoroacetic acid. Trypsinised eluents
were collected after a brief centrifugation then purified and desalted using selfpacked tips with six layers of C18 Empore disks (Pacific Laboratory Products),
then dried in a SpeedVac. Samples were then resuspended in 12 µl 5% formic
acid, 2% acetonitrile and stored at −80°C.
For nano-liquid chromatography tandem mass spectrometry (nLC-MS/MS)
analysis, 5 µl of each of the peptide samples were loaded and separated
along a C18 column (400 mm, 75 µm ID, 3 µm silica beads) and introduced
by nanoelectrospray into an LTQ Orbitrap Velos Pro coupled to an EasynLC HPLC (Thermo Fisher). MS/MS data were collected for the top ten
most abundant ions per scan over a 140-min time gradient. The order of data
collection was randomised to interchange between biological conditions
with BSA run between each sample to minimise temporal bias. MS/MS raw
files were analysed using the Andromeda search engine integrated into
MaxQuant (v1.2.7.4) (Cox and Mann, 2008) against the Uniprot Mouse
database. A false discovery rate of 1% was tolerated for protein, peptide and
sites, and one missed cleavage was allowed. MaxQuant output data were
filtered to remove contaminants, reverse hits, proteins only identified by site
and proteins with <2 unique peptides (Croucher et al., 2016). An individual
protein was defined as present under a particular condition if it was detected
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in a minimum of two replicates. Protein–protein interactions and KEGG
pathway analysis among the resulting protein list was analysed using
STRING (v10) (Szklarczyk et al., 2015) (with a confidence score of 0.700)
and Cytoscape (v3.1.1) (Smoot et al., 2011).
Analysis of mitochondrial morphology and function

NSC-34 cells transiently transfected with SOD1WT-GFP or SOD1A4V–GFP
were incubated with 100 nM Mitotracker Deep Red FM (Molecular Probes)
or Mitotracker CMXRos (Molecular Probes) for 30 min at 37°C prior to
analysis by confocal microscopy or flow cytometry at 48 h post transfection.
Mitochondrial morphology was examined with a mitochondrial morphology
macro (Dagda et al., 2009) on ImageJ 1.48v. Mitotracker Red and Mitotracker
CMXRos accumulation in cells expressing high levels of SOD1–GFP was
also assessed by flow cytometry (Becton Dickinson).
Acknowledgements
The authors would like to gratefully acknowledge Clare Watson who helped with
editing and proof reading the manuscript.

Competing interests
The authors declare no competing or financial interests.

Author contributions
Conceptualization: N.E.F., D.N.S., J.J.Y.; Methodology: N.E.F., I.L.-S., J.M., L.M.,
K.L.V., D.N.S., J.J.Y.; Validation: I.L.-S.; Formal analysis: K.M., J.M., P.C., K.L.V.,
D.N.S., J.J.Y.; Investigation: P.C., J.J.Y.; Resources: D.N.S., J.J.Y.; Data curation:
N.E.F., K.M., L.M., P.C.; Writing - original draft: N.E.F., J.J.Y.; Writing - review &
editing: N.E.F., I.L.-S., L.M., P.C., K.L.V., D.N.S., J.J.Y.; Visualization: N.E.F.;
Supervision: K.L.V., D.N.S., J.J.Y.; Project administration: K.L.V., J.J.Y.; Funding
acquisition: K.L.V., D.N.S., J.J.Y.

Funding
I.L.-S. was supported by Australian Rotary Health. P.C. was supported by grants
from the US-UK Fulbright Commission, St John’s College, University of Cambridge,
and the National Institutes of Health (Northwestern University Medical Scientist
Training Program Grant T32 GM8152-28). D.N.S., K.L.V. and J.J.Y. were supported
by US Department of Defense (AL150057) and the Motor Neuron Disease Research
Institute of Australia (Cunningham Family MND research grant, GIA1656). J.J.Y. was
also supported by grants from the National Health and Medical Research Council
(1095215, 1084144). Deposited in PMC for release after 12 months.

Data availability
The datasets used and/or analysed during the current study are available from the
corresponding author on reasonable request.

Supplementary information
Supplementary information available online at
http://jcs.biologists.org/lookup/doi/10.1242/jcs.209122.supplemental

References
Atkin, J. D., Farg, M. A., Soo, K. Y., Walker, A. K., Halloran, M., Turner, B. J.,
Nagley, P. and Horne, M. K. (2014). Mutant SOD1 inhibits ER-Golgi transport in
amyotrophic lateral sclerosis. J. Neurochem. 129, 190-204.
Bence, N. F., Sampat, R. M. and Kopito, R. R. (2001). Impairment of the ubiquitinproteasome system by protein aggregation. Science 292, 1552-1555.
Bergink, S., Salomons, F. A., Hoogstraten, D., Groothuis, T. A., de Waard, H.,
Wu, J., Yuan, L., Citterio, E., Houtsmuller, A. B., Neefjes, J. et al. (2006). DNA
damage triggers nucleotide excision repair-dependent monoubiquitylation of
histone H2A. Genes Dev. 20, 1343-1352.
Boeynaems, S., Bogaert, E., Kovacs, D., Konijnenberg, A., Timmerman, E.,
Volkov, A., Guharoy, M., De Decker, M., Jaspers, T., Ryan, V. H. et al. (2017).
Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics.
Mol. Cell 65, 1044-1055 e5.
Brettschneider, J., Arai, K., Del Tredici, K., Toledo, J. B., Robinson, J. L., Lee,
E. B., Kuwabara, S., Shibuya, K., Irwin, D. J., Fang, L. et al. (2014). TDP-43
pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta
Neuropathol. 128, 423-437.
Cashman, N. R., Durham, H. D., Blusztajn, J. K., Oda, K., Tabira, T., Shaw, I. T.,
Dahrouge, S. and Antel, J. P. (1992). Neuroblastoma x spinal cord (NSC) hybrid
cell lines resemble developing motor neurons. Dev. Dyn. 194, 209-221.
Chen, S., Sayana, P., Zhang, X. and Le, W. (2013). Genetics of amyotrophic lateral
sclerosis: an update. Mol. Neurodegener 8, 28.

Journal of Cell Science (2018) 131, jcs209122. doi:10.1242/jcs.209122

Cheroni, C., Marino, M., Tortarolo, M., Veglianese, P., De Biasi, S., Fontana, E.,
Zuccarello, L. V., Maynard, C. J., Dantuma, N. P. and Bendotti, C. (2009).
Functional alterations of the ubiquitin-proteasome system in motor neurons of a
mouse model of familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, 82-96.
Chiti, F. and Dobson, C. M. (2006). Protein misfolding, functional amyloid, and
human disease. Annu. Rev. Biochem. 75, 333-366.
Ciechanover, A. and Brundin, P. (2003). The ubiquitin proteasome system in
neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron
40, 427-446.
Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond,
C. S., Couthouis, J., Lu, Y. F., Wang, Q., Krueger, B. J. et al. (2015). Exome
sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.
Science 347, 1436-1441.
Ciryam, P., Tartaglia, G. G., Morimoto, R. I., Dobson, C. M. and Vendruscolo, M.
(2013). Widespread aggregation and neurodegenerative diseases are associated
with supersaturated proteins. Cell Rep. 5, 781-790.
Ciryam, P., Kundra, R., Morimoto, R. I., Dobson, C. M. and Vendruscolo, M.
(2015). Supersaturation is a major driving force for protein aggregation in
neurodegenerative diseases. Trends Pharmacol. Sci. 36, 72-77.
Ciryam, P., Kundra, R., Freer, R., Morimoto, R. I., Dobson, C. M. and
Vendruscolo, M. (2016). A transcriptional signature of Alzheimer’s disease is
associated with a metastable subproteome at risk for aggregation. Proc. Natl.
Acad. Sci. USA 113, 4753-4758.
Ciryam, P., Lambert-Smith, I. A., Bean, D. M., Freer, R., Cid, F., Tartaglia, G. G.,
Saunders, D. N., Wilson, M. R., Oliver, S. G., Morimoto, R. I. et al. (2017).
Spinal motor neuron protein supersaturation patterns are associated with
inclusion body formation in ALS. Proc. Natl. Acad. Sci. USA 114, E3935-E3943.
Cox, J. and Mann, M. (2008). MaxQuant enables high peptide identification rates,
individualized p.p.b.-range mass accuracies and proteome-wide protein
quantification. Nat. Biotechnol. 26, 1367-1372.
Croucher, D. R., Iconomou, M., Hastings, J. F., Kennedy, S. P., Han, J. Z.,
Shearer, R. F., McKenna, J., Wan, A., Lau, J., Aparicio, S. et al. (2016).
Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific
protein interactions for ERBB2 dimers. Sci. Signal. 9, ra69.
Dagda, R. K., Cherra, S. J., III, Kulich, S. M., Tandon, A., Park, D. and Chu, C. T.
(2009). Loss of PINK1 function promotes mitophagy through effects on oxidative
stress and mitochondrial fission. J. Biol. Chem. 284, 13843-13855.
Dantuma, N. P., Groothuis, T. A., Salomons, F. A. and Neefjes, J. (2006). A
dynamic ubiquitin equilibrium couples proteasomal activity to chromatin
remodeling. J. Cell Biol. 173, 19-26.
Farrawell, N. E., Lambert-Smith, I. A., Warraich, S. T., Blair, I. P., Saunders, D. N.,
Hatters, D. M. and Yerbury, J. J. (2015). Distinct partitioning of ALS associated
TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 5, 13416.
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